Additionally, our exploration into B7‐H3's biological activities in NB, under both cisplatin‐treated and untreated scenarios, demonstrated that the silencing of B7‐H3 markedly diminishes the IC50 values for cisplatin in resistant NB cells across various concentrations. The gene discussed is CD276; the disease is neuroblastoma.